We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

EUROIMMUN AG

EUROIMMUN is an international provider of medical laboratory products for autoimmune, infection, allergy and molecula... read more Featured Products: More products

Download Mobile App




Multiparametric Serological Testing Aids Diagnosis of Autoimmune Encephalitis

By LabMedica International staff writers
Posted on 09 Dec 2016
Autoimmune encephalitides can manifest with diverse neurological symptoms, including memory deficits, neuropsychiatric conditions and epileptic seizures, and may or may not be associated with cancer.

Timely diagnosis is important, as immediate treatment can prevent irreversible damage to the brain. More...
Particularly in unexplained neurological cases, a comprehensive autoantibody screening can help to establish a diagnosis, enabling rapid commencement of life-saving therapy. Since many of the autoantibody markers are rare, multiparametric screening composed of different transfected-cell substrates is recommended to increase the diagnostic detection rate.

Scientists at the Institute for Experimental Immunology (Euroimmun AG, Lübeck, Germany) tested a cohort that consisted of 2,716 serum samples received between October and December 2010. The samples were tested on a biochip mosaic combining different neuronal tissue sections with monospecific cell substrates for the detection of antibodies against NMDA receptor (NR1), AMPA receptor (GluR1/GluR2), GABAB receptor, LGI1, CASPR2, GAD65, AQP4, and GlyR.

The team found anti-neuronal immunoglobulin G (IgG) in 108 samples with anti-NMDA receptor antibodies being by far the most prevalent finding (38%), followed by anti-LGI1 (11%) and anti-CASPR2 antibodies (11%). In total, more than 60% of the samples were positive for autoantibodies against neuronal surface antigens, while autoantibodies against classical paraneoplastic intracellular antigens were detected in 31%. The high prevalence of autoantibodies against cell surface antigens in CNS underscores the rising relevance of this novel class of neuronal antigens for autoimmune encephalitis diagnostics.

The evaluation of anti-neuronal autoantibodies was then automated using a new function of the established EUROPattern system. The software automatically takes digital images of the substrates and provides a positive/negative classification. The high-resolution images are sharply focussed with the aid of a counterstain, which also serves to verify correct performance of the incubation. The high-quality of the images was verified by comparing on-screen appraisal with visual microscopy using 753 incubations of numerous serum samples sent to a clinical immunology laboratory.

The two evaluation strategies revealed a concordance of 100% with respect to positive/negative discrimination (excluding samples with ambiguous signals at the microscope to avoid inter-reader deviations). The computer-aided immunofluorescence microscopy considerably facilitates the microscopic analysis, supporting laboratory personnel in the rapid issuance of diagnostic findings. This confirmed the high quality of the images and proves that on-screen evaluation offers a satisfying diagnostic accuracy which can compete with classical immunofluorescence microscopy. The study was published originally published on line on August 1, 2016, in the journal Autoimmunity Reviews.

Related Links:
Euroimmun


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.